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Abstract 
Background: Diabetes mellitus is becoming a big public health challenge, particularly in developing countries like 
Ethiopia. It is a manageable disease if early screening and follow up is made. However, as studies in Ethiopia are lim-
ited and unorganized, determining the magnitude of prediabetes and diabetes and identifying associated risk factors 
is quite essential.
Methods: A community-based, cross-sectional study was conducted from February to April 2015 among adults 
(aged ≥20 years) in a rural Koladiba town. A multistage sampling technique was used to select a total of 392 study 
participants. Data were collected after a fully informed written consent was obtained from each participant. Demo-
graphic, behavioral, and clinical data were collected using a well-structured questionnaire. Multivariable logistic 
regression models were fitted to control the effect of confounders. Adjusted odds ratios (AOR) with their 95% confi-
dence intervals (95% CI) were computed to measure associations. A p value of <0.05 was considered as statistically 
significant.
Results: The prevalence of impaired fasting glucose and undiagnosed diabetes mellitus were 12% (95% CI 9–16) 
and 2.3% (95% CI 1.1–4), respectively, in Koladiba. Overweight (AOR: 4.257, 95% CI 1.345–13.476), obesity (AOR: 5.26, 
95% CI 1.138–24.316), hypertriglyceridemia (AOR: 2.83, 95% CI 1.451–5.521), and systolic hypertension (AOR: 3.858, 
95% CI 1.62–9.189) were found to be independently associated with impaired fasting glucose. Positive family history 
of diabetes also showed a marginal association with impaired fasting glucose (p = 0.057). Male sex (p = 0.012) and 
hypertriglyceridemia (p = 0.030) were associated with undiagnosed diabetes mellitus.
Conclusions: The prevalence of impaired fasting glucose and undiagnosed diabetes mellitus are found to be signifi-
cant. Obesity, hypertriglyceridemia, and systolic hypertension are independently associated with impaired fasting glu-
cose among adults. We recommend that the community be aware of healthy life style, early screening, and maintain 
continuous follow up.
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Background
Diabetes mellitus (DM) is a metabolic disorder of mul-
tiple etiologies, characterized by chronic hyperglycemia 
with disturbances of carbohydrate, fat, and protein 
metabolism resulting from defects in insulin secretion, 
action or both [1]. Diabetes is one of the most common 
metabolic disorders in the world, and its prevalence has 
been increasing in the last decades [2]. Diabetes exerts a 
high burden in sub-Saharan Africa, and this is expected 
to increase from time to time. Many DM patients face 
challenges in accessing diagnosis and treatment in this 
Open Access
BMC Research Notes
*Correspondence:  mollish77@gmail.com 
4 Department of Clinical Chemistry, School of Biomedical and Laboratory 
Sciences, College of Medicine and Health Sciences, University of Gondar, 
Gondar, Ethiopia
Full list of author information is available at the end of the article
Page 2 of 7Worede et al. BMC Res Notes  (2017) 10:251 
region which contributes to significant morbidity and 
mortality rates [3].
Ethiopia is one of the four most populous countries 
which have the highest numbers of people with diabetes 
in Africa. The number of people with diabetes is increas-
ing in every region of Ethiopia. According to Interna-
tional Diabetes Federation Atlas (IDFA) in 2013, there 
were 1.9 million diabetes cases of 20–79 years aged peo-
ple and 34,262 diabetes related deaths and 1.2 million of 
them were in the rural setting. More than 1 million of 
this people were living with undiagnosed diabetes mel-
litus [4]. The estimated prevalence of diabetes among 
the Ethiopian adult (20–79 years) population was 2% [5], 
3.5% [2] and 4.4% [6] in 2010, 2011 and 2013, respec-
tively. Increasing urbanization, aging population, obesity, 
and physical inactivity are all contributing to the rise of 
diabetes worldwide [7].
Individuals with impaired fasting glucose (IFG) have 
been referred to as having prediabetes, indicating the rel-
atively high risk for the future development of diabetes. 
IFG should not be viewed as a clinical entity in its own 
right but rather as a risk factor for diabetes and cardio-
vascular disease (CVD). It is associated with obesity, dys-
lipidemia, and hypertension [8, 9].
The chronic hyperglycemia of DM is associated with 
a long-term damage, dysfunction, and failure of vari-
ous organs, especially the eyes, nerves, kidneys, heart, 
and blood vessels [10]. As a result of poor diagnosis and 
awareness in communities, DM complications are com-
mon in sub-Saharan Africa. Thus, people with diabe-
tes (known or unknown) visit health facilities because 
of complications rather than for routine consultation 
or follow-up [11]. DM is a chronic illness that requires 
ongoing medical care and continuing patient self-
management education and support to prevent acute 
complications and to reduce the risk of long-term com-
plications. In addition, diabetes care is complex and 
needs multifactorial risk reduction strategies beyond 
glycemic control [8].
Findings from different studies indicated that indi-
viduals with prediabetes could prevent the onset of type 
2 diabetes by losing their body weight through physical 
exercise and dietary management, behavior modifica-
tion and medications [12, 13]. Although IFG is an early 
alert system which offers a warning to prevent the future 
development of DM and diabetes-related complications, 
there is limited data regarding the prevalence of predia-
betes (IFG), undiagnosed DM and associated risk factors 
in Ethiopia. Therefore, this study will provide baseline 
information regarding the magnitude of prediabetes, 
undiagnosed DM and associated risk factors in Ethiopian 
setting, which will be used to minimize the increasing 
prevalence of DM and associated complications.
Methods
Study population, design, setting and period
The study included adults (20  years and above) who 
were living in the study area and volunteered to give 
informed written consent. Pregnant women, individuals 
who were taking drugs with a possible impact on glucose 
metabolism (e.g. steroids, B-blockers, thiazide diuret-
ics), diabetes mellitus confirmed individuals, and criti-
cally ill patients who were not able to communicate were 
excluded from the study.
A community-based, cross-sectional study was con-
ducted from February to April 2015 in a rural Koladiba 
town of Dembia district. Koladiba town is located in the 
Amhara National Regional State, 729  km from Addis 
Ababa, the capital city of Ethiopia. The town has 17,500 
inhabitants, living in 8 small administrative unites called 
“Ketenas”, very close to Lake Tana. The town has one 
health center.
Sampling techniques and sample size determination
A multistage sampling technique was applied to select 
the participants. Four ketenas (smallest administrative 
units with similar demographics) were selected randomly 
via the lottery method from a total of 8 ketenas. Then, 
all households in the 4 ketenas with the age of 20 years 
and above were considered as a sampling unit. A random 
sampling technique (lottery method) was employed to 
select each household proportionally (because the num-
ber of households in selected ketenas was not equal). 
When there was more than one eligible subject in each 
household, one of them was selected randomly by the lot-
tery method. The sample size was determined using the 
single population proportion formula by considering: a 
15% prevalence of prediabetes from a previous study in 
southwest Ethiopia [14], a 5% level of significance, and 
a 0.05% margin of error. The calculated result (196) was 
multiplied by the design effect of 2; therefore, the final 
sample size was 392.
Data collection
Demographic, behavioral, and clinical data of the study 
participants were collected using a pretested and struc-
tured questionnaire. Data collectors were trained nurses 
supervised by experienced professionals. Blood sample 
was also collected by trained medical laboratory profes-
sionals. A 4-day training and practical demonstration 
was given to the data collectors on the objective of the 
study, procedure of blood sample collection, procedures 
of measurement, confidentiality of information, respond-
ents’ rights and the techniques of interview prior to the 
data collection.
After the interview was made in the evening, the par-
ticipants were instructed to be on overnight fasting 
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(10–16 h). The next morning, 3–5 ml venous blood was 
collected using a plain vacutainer tube. The blood sample 
was left at room temperature to be clotted for 15–20 min 
and centrifuged at 3000 rpm for 10 min. Then, sera was 
transferred to 2  ml Eppendorf tubes and stored at 4  °C 
for 1–2  h at sample collection sites and transported to 
the Clinical Chemistry Laboratory of the University of 
Gondar Hospital. The blood level of glucose was deter-
mined by the glucose oxidase method and the total 
cholesterol and triglycerides were measured by the enzy-
matic colorimetric method using the Mindray BS-200 
Chemistry Analyzer (Mindray Medical International 
LTD, China).
Normal fasting blood glucose (FBG) refers to FBG 
level below 100  mg/dl, without a history of diabetic 
medication. Impaired fasting glucose (IFG) refers to a 
level of blood glucose between 100 and 125 mg/dl with 
no diabetic medication. Diabetes manifests when the 
FBG level equals or exceeds 126  mg/dl, or a history of 
diabetic medication exists. Undiagnosed diabetes mel-
litus is defined as unknowingly having an elevated glu-
cose level that meets the definition of diabetes mellitus 
[10]. The cutoff points to categorize hyperlipidemia were 
total cholesterol (TC) ≥200 mg/dl and triglycerides (TG) 
≥150 mg/dl [15].
Measurements
Standardized techniques and calibrated equipments were 
used for anthropometric measurements. Each eligible 
subject was weighed to the nearest 0.1 kg in light indoor 
clothing and bare feet or with stockings. Body mass index 
(BMI) (kg/m2) was calculated using study participants’ 
height and weight. Height was measured using a portable 
stadiometer. BMI was classified as <18.5  kg/m2 under-
weight, 18.5–24.9  kg/m2 normal, 25–29.9  kg/m2 over-
weight and ≥30 kg/m2 obese. Waist circumference (WC) 
was measured at the midpoint between the lower margin 
of the least palpable rib and the top of the iliac crest. WC 
values of >102 and >88 cm for males and females, respec-
tively, were considered high, according to World Health 
Organization.
The systolic blood pressure (SBP) and diastolic blood 
pressure (DBP) of each participant were measured two 
times using a mercury sphygmomanometer, while the 
participants were in a sitting position and after 15  min’ 
rest. The second BP measurement was taken after 5 min 
of the first measurement. Then, the average value was 
calculated and taken as the BP result. SBP ≥ 140 mmHg 
or DBP  ≥  90  mmHg or reported use of regular anti-
hypertensive drugs were considered to define hyperten-
sion [15].
Data analysis
The statistical package for social sciences (SPSS) version 
20 (IBM, USA) software was used for data entry and 
analysis. Bivariable and multivariable logistic regression 
models were fitted to identify possible associated risk 
factors with impaired fasting glucose. Variables with 
a p value of ≤0.2 in the bivariable analysis were main-
tained in the multivariable model to control the effect of 
confounding variables. The Hosmer–Lemeshow good-
ness-of-fit statistic was used to assess the fitness of the 
model. Both crude and adjusted odds ratios with their 
95% confidence intervals (CI) were computed to meas-
ure the strengths of associations between variables. 
However, odds ratios can be biased when the rare dis-
ease assumption is violated, generally when the preva-
lence is greater than 10%, which is the case for IFG in 
this population. Fisher’s exact test was used to evaluate 
the association of risk factors with undiagnosed diabe-
tes mellitus. A p value of <0.05 was considered as statis-
tically significant.
Operational definitions
Family history of DM was considered as positive if either 
or both parents or siblings of individuals were diagnosed 
to have DM. Smoking habit was reported as “nonsmoker” 
(for individuals who never smoked) and “smoker” (for 
individuals who were smoking at the moment).
Results
Socio‑demographic characteristics of study participants
Five percent of the selected individuals were disagreed to 
participate in this study because of fear of venipuncture 
for blood sample collection and other reasons. Additional 
participants were invited in place of the above disagreed 
individuals to fulfill the calculated sample size. Three 
hundred ninety-two adult participants with the mean age 
of 43.76 ± 17.29 years (range 20–90 years) were included. 
The majority, 219 (55.9%), of the participants were 
females; 235 (59.9%) were married; 336 (85.7%) were 
Orthodox christian and 126 (32.1%) unable to read and 
write (illiterate) (Table 1).
Prevalence of impaired fasting glucose and undiagnosed 
DM
According to the American Diabetes Association (ADA) 
fasting criteria, the prevalence of impaired fasting glu-
cose (IFG) and undiagnosed diabetes mellitus (DM) 
among participants were 12% (95% CI 9–16) and 2.3% 
(95% CI 1.1–4), respectively. Among study participants, 
the prevalence of IFG was almost similar for sexes, 5.9% 
for males and 6.1% for females (Table 2).
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Factors associated with IFG and undiagnosed DM
In the bivariate analysis, age, smoking habit, family his-
tory of diabetes mellitus (DM), body mass index (BMI), 
waist circumference (WC), total cholesterol (TC), triglyc-
erides (TG), systolic blood pressure (SBP), and diastolic 
blood pressure (DBP) were found to be significantly asso-
ciated with the prevalence of impaired fasting glucose 
(Table 3).
The multivariate logistic regression analysis showed 
that BMI, SBP, and TG were independently associated 
with IFG. Table  3 below shows that the odds of IFG 
was 4.26 times higher among overweight subjects com-
pared with underweight subjects (AOR = 4.257, 95% CI 
1.345–13.476). Obese individuals were 5.26 times more 
likely to be prediabetic than underweight individuals 
(AOR  =  5.26, 95% CI 1.138–24.316). Individuals with 
systolic hypertension were 3.86 times more likely to 
have IFG as compared to the non-hypertensive individ-
uals (AOR =  3.858, 95% CI 1.62–9.189). Study subjects 
with hypertriglyceridemia showed higher odds (2.83) of 
IFG than individuals who had normal triglycerides level 
(AOR = 2.83, 95% CI 1.451–5.521). Furthermore, a posi-
tive family history of diabetes also showed a marginal 
association with IFG (p = 0.057).
Fisher’s exact test was used to measure the association 
between undiagnosed DM and risk factors because the 
cases were few. Therefore, an undiagnosed DM was sig-
nificantly associated with male sex and hypertriglyceri-
demia (p = 0.012 and 0.030), respectively.
Discussion
In this study, around one in eight adults (20  years and 
above) had impaired fasting glucose (IFG) [12% (95% CI 
9–16)], a condition that increases the risk for diabetes. 
Table 1 Socio-demographic characteristics of  study par-
ticipants in  Koladiba town of  Dembia district, northwest 
Ethiopia, 2015 (n = 392)
Variable Category Number Percent
Sex Male 173 44.1
Female 219 55.9
Age 20–29 106 27.0
30–39 72 18.4
40–49 67 17.1
50–59 58 14.8
>60 89 22.7
Occupation Employed 85 21.7
Housewife 114 29.1
Student 25 6.4
Merchant 63 16.1
Daily laborer 75 19.1
Farmer 30 7.7
Marital status Married 235 59.9
Single 60 15.3
Divorced 45 11.5
Widowed 47 12.0
Separated 5 1.3
Educational status Not read and write 126 32.1
Primary school 111 28.3
Secondary school 115 29.3
Higher education 40 10.2
Religion Orthodox christian 336 85.7
Protestant christian 4 1.0
Muslim 52 13.3
Table 2 IFG and  undiagnosed DM by  socio-demographic 
characteristics of  the study participants in  Koladiba town 
of Dembia district, northwest Ethiopia, 2015
IFG impaired fasting glucose, N/n number, NFG normal fasting glucose, UDM 
undiagnosed diabetes mellitus, % percent
Parameter NFG (n = 336, 
% = 85.7) N %
IFG (n = 47, 
% = 12) N %
UDM (n = 9, 
% = 2.3) N %
Sex
 Male 142 (36.2) 23 (5.9) 8 (2)
 Female 194 (49.5) 24 (6.1) 1 (0.3)
Age
 20–29 99 (25.3) 6 (1.5) 1 (0.3)
 30–39 66 (16.8) 6 (1.5) 0 (0)
 40–49 51 (13) 13 (3.3) 3 (0.8)
 50–59 46 (11.7) 10 (2.6) 2 (0.5)
 >60 74 (18.9) 12 (3.1) 3 (0.8)
Occupation
 Employed 71 (18.1) 12 (3.1) 2 (0.5)
 Housewife 100 (25.5) 13 (3.3) 1 (0.3)
 Student 23 (5.9) 2 (0.5) 0 (0)
 Merchant 49 (12.5) 9 (2.3) 5 (1.3)
 Daily laborer 68 (17.3) 6 (1.5) 1 (0.3)
 Farmer 25 (6.4) 5 (1.3) 0 (0)
Marital status
 Married 196 (50) 31 (7.9) 8 (2)
 Single 55 (14) 5 (1.3) 0 (0)
 Divorced 42 (10.7) 3 (0.8) 0 (0)
 Widowed 38 (9.7) 8 (2) 1 (0.3)
 Separated 5 (1.3) 0 (0) 0 (0)
Educational status
 Not read and write 112 (28.6) 14 (3.6) 0 (0)
 Primary school 93 (23.7) 13 (3.3) 5 (1.3)
 Secondary school 96 (24.5) 16 (4.1) 3 (0.8)
 Higher education 35 (8.9) 4 (1) 1 (0.3)
Religion
 Orthodox christian 287 (73.2) 43 (11) 6 (1.5)
 Protestant christian 3 (0.8) 1 (0.3%) 0 (0)
 Muslim 46 (11.7) 3 (0.8%) 3 (0.8)
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This result is slightly lower than a population based 
cross-sectional survey done in another sub-Saharan Afri-
can country, Uganda (20%) [16]. This disagreement might 
be due to the age difference in the study population; we 
included adults 20–90  years of age with 43.76  ±  17.29 
mean age, while the Ugandan study consisted of an 
older population of 35–60  years. Moreover, our finding 
was slightly lower than that of a study conducted in Iran 
(16.8%) [17] for perhaps, the same reason and owing to 
the fact that the Iranian study involved both rural and 
urban dwellers. Our result was similar to that of a study 
carried out in Poland (9.5%) [18].
In the current study, the prevalence of IFG was not asso-
ciated with sex which is in line with another study in Bra-
zil [19]. Studies in South Africa [20], Mauritius [21], India 
[22], and USA [23] confirmed that IFG was higher in males 
than females. To the contrary, a study in Saudi Arabia [24] 
presented an opposite finding. These discrepancies need 
further investigation to discover the underling etiology. The 
multivariate analysis showed that age was not associated 
with IFG, while the bivariate analysis showed the opposite. 
Small sample size might have its own effect. Unlike our 
finding, several studies reported that the prevalence of IFG 
had a positive association with older age [25–28].
Regarding our finding, overweight, obesity, hypertri-
glyceridemia and systolic hypertension were associated 
with IFG. Positive family history of diabetes also showed 
a marginal association. Therefore, overweight and obese 
individuals were risk groups for the development of IFG 
which was consistent with findings reported by other 
community-based studies [16, 20, 22, 27]. It has already 
been a confirmed fact that obesity causes insulin resist-
ance (affect insulin action), and decreases insulin-stim-
ulated glucose disposal, leading to the development of 
IFG and diabetes mellitus consecutively. Hypertriglyc-
eridemia has a similar scenario with obesity because its 
blood level is directly related to total body fat accumu-
lation [29]. Moreover, our result demonstrated that IFG 
Table 3 Bivariate and multivariate analysis of factors associated with IFG in Koladiba town of Dembia district, northwest 
Ethiopia, 2015 (n = 383)
AOR adjusted odds ratio, BMI body mass index, CI confidence interval, COR crude odds ratio, DBP diastolic blood pressure, DM diabetes mellitus, FHDM family history 
of diabetes mellitus, IFG impaired fasting glucose, SBP systolic blood pressure, SH smoking habit TC total cholesterol, TG triglycerides, WC waist circumference
* Marginal significance (p = 0.057)
** p < 0.05
*** p < 0.01
Variable Category IFG COR (95% CI) AOR (95% CI)
Yes No
Age 20–29 6 99 1 1
30–39 6 66 1.5 (0.464–4.851) 0.657 (0.17–2.545)
40–49 13 51 4.206 (1.510–11.718) 2.275 (0.705–7.34)
50–59 10 46 3.587 (1.229–10.466) 1.671 (0.495–5.638)
≥60 12 74 2.676 (0.960–7.459) 1.737 (0.559–5.402)
SH Non-smokers 42 327 1 1
Smokers 5 9 4.325 (1.384–13.517) 2.647 (0.714–9.809)
FHDM Yes 14 35 3.648 (1.782–7.469) 2.193 (0.976–4.926)*
No 33 301 1 1
BMI Underweight 5 85 1 1
Normal 21 205 1.741 (0.636–4.770) 1.419 (0.504–3.993)
Overweight 16 37 7.351 (2.507–21.557) 4.257 (1.345–13.476)**
Obese 5 9 9.444 (2.289–38.966) 5.26 (1.138–24.316)**
WC Low risk 25 249 1 1
High risk 22 87 2.519 (1.351–4.695) 1.132 (0.474–2.703)
TC Normal 31 279 1 1
High 16 57 2.526 (1.296–4.923) 1.713 (0.8–3.668)
TG Normal 21 245 1
High 26 91 3.333 (1.787–6.217) 2.83 (1.451–5.521)***
SBP Non-hypertensive 35 315 1 1
Hypertensive 12 21 5.143 (2.333–11.338) 3.858 (1.62–9.189)***
DBP Non-hypertensive 37 309 1 1
Hypertensive 10 27 3.093 (1.387–6.895) 0.97 (0.333–2.826)
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had a positive association with systolic hypertension 
which is confirmed somewhere else [20, 22, 27]. The 
other established fact is that insulin resistance is a com-
mon pathophysiologic feature of obesity, glucose intoler-
ance and, hypertension [30].
The prevalence of undiagnosed DM was 2.3% (95% CI 
1.1−4) in this study. This prevalence is comparable with 
that of Iran (3.85%) [17] and USA (2.8%) [23]. Another 
study in northwest Ethiopia confirmed that the propor-
tion of previously undiagnosed DM cases was high in 
both urban and rural settings, while the rate was much 
higher in rural population. This finding may reflect the 
low awareness of the community, the public, and primary 
health care providers about DM [31]. In addition, stud-
ies in sub-Saharan Africa identified that more than 40% 
of the DM cases were previously undiagnosed [3]. Even 
though the low number of cases limited our analysis of 
associated risk factor determination, Fisher’s exact test 
demonstrated that male sex (p  =  0.012) and hypertri-
glyceridemia (p  =  0.03) showed a positive association 
with undiagnosed DM. Other studies also strengthen this 
finding because of the evidences described under IFG in 
the paragraphs above [20, 22, 23, 27].
In our study, exclusion of known patients with diabetes 
mellitus may have affected the prevalence estimate of diabe-
tes. Greater awareness of the age related nature of diabetes 
may have lead to more recognition of the disorder in these 
age groups, leaving fewer at risk individuals to be detected 
in this study. In addition, small sample size and more of 
younger study population may lower the diabetes estimate.
Limitations of this study
Primarily, this study did not include patients with diag-
nosed diabetes mellitus. Therefore, undiagnosed diabe-
tes mellitus alone could not show the exact magnitude 
of diabetes mellitus in the community. Secondly, some 
essential factors like diet and physical activity were not 
assessed because it was not possible to standardize the 
data obtained from study participants. Thirdly, in com-
parison to other similar studies, the number of study 
participants was low (because of budget shortage we 
were unable to include more participants) which may 
under or over estimate the prevalence of IFG and undi-
agnosed diabetes mellitus. Furthermore, this is a study in 
one rural town and therefore not representative of rural 
Ethiopia at large, where as it could be used as baseline for 
further studies with large geographical area.
Conclusion
The prevalence of IFG was found to be high among adults 
(age  ≥  20) in Koladiba town. Factors like, overweight, 
obesity, hypertriglyceridemia, systolic hypertension, 
and positive family history of diabetes were found to be 
significantly associated with IFG. Hypertriglyceridemia 
also showed a positive association with undiagnosed dia-
betes mellitus. We recommend that awareness should be 
created regarding healthy life style, early diagnosis and 
treatment of prediabetes and diabetes. In addition, fast-
ing plasma glucose value is recommended for screening 
IFG and diabetes currently because it is quick, easy to 
determine, and acceptable to patients in clinical settings. 
Therefore, it is advisable to visit health facilities periodi-
cally for health checkup including diabetes mellitus.
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